Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19–associated rhino-orbito-cerebral mucormycosis: author's response

dc.contributor.authorMukaka M.
dc.contributor.authorManesh A.
dc.contributor.authorVarghese G.M.
dc.contributor.otherMahidol University
dc.date.accessioned2023-09-04T18:01:49Z
dc.date.available2023-09-04T18:01:49Z
dc.date.issued2023-01-01
dc.identifier.citationClinical Microbiology and Infection (2023)
dc.identifier.doi10.1016/j.cmi.2023.07.019
dc.identifier.eissn14690691
dc.identifier.issn1198743X
dc.identifier.pmid37516382
dc.identifier.scopus2-s2.0-85168853853
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/89290
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleShort intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19–associated rhino-orbito-cerebral mucormycosis: author's response
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85168853853&origin=inward
oaire.citation.titleClinical Microbiology and Infection
oairecerif.author.affiliationMahidol Oxford Tropical Medicine Research Unit
oairecerif.author.affiliationNuffield Department of Medicine
oairecerif.author.affiliationChristian Medical College, Vellore

Files

Collections